
WhiteLab Genomics Showcased AI-Driven Outcomes Advancing the Future of Genomic Medicine at ASGCT 2025
Thank you for your interest in our posters! At Whitelab Genomics, we specialize in using artificial intelligence to accelerate the development of genomic medicines. The following four research posters were presented at the 28th Annual Congress of the American Society of Gene & Cell Therapy (ASGCT), which took place May 13-17th, 2025 in New Orleans, USA.
Enhancing AAV Gene Therapy Targeting Retinal Diseases with AI-Guided Rational Design
Authors: A.Barberis, B. Dafniet, T. Van Meter, U. Ferrari, P. El Darazi, D. Serillon, D. Dalkara, J. Cottineau
WhiteLab Genomics, Future4Care, 8 rue Jean Antoine de Baïf, 75013 Paris, France
Institut de la Vision, Paris, France

Novel In Silico Generation of a Synthetic Peptide Library Derived from Biological Complexes for Protein and Vector Engineering
Authors: C.Alliot, B.Dafniet, Y.Habtoun, C.Colas, J.Maes, D. DelBourgo, J.Cottineau, D.Serillon
WhiteLab Genomics FUTURE4CARE, 8 rue Jean Antoine de Baif, 75013 Paris, France

Revolutionizing Peptide Discovery: AI-Driven Drug Design Paving the Way for the Future of Cell & Gene Therapy
Authors: C. Alliot, C. Colas, B. Dafniet, J. Maes, J-P. Buffet, P. Vidal, A. Murza, D. Del Bourgo, J.Cottineau, P-L. Boudreault, D. Serillon
WhiteLab Genomics, FUTURE4CARE, 8 rue Jean Antoine de Baif, 75013 Paris, France
Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, J1H 5N4 Sherbrooke, Québec, Canada

More Details
Click here to view abstracts and presenter videos